Vaishali Pharma share news, announcements and annual reports
NSE: VAISHALIPharmaceuticals & BiotechnologySmall Cap
Vaishali Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2017 · Issue price ₹40
Last close ₹6.51up ₹0.09 (1.40%)
Share price at the NSE close on 2 Nov 2026. Previous close ₹6.42.
2 Nov: open ₹6.45, high ₹6.68, low ₹6.40
52-week range of traded prices to 2 Nov 2026
₹4.75Low, 30 Mar 2026₹10.27High, 3 Nov 2025
- The board meets on 5 Nov 2026 to consider: fund raising and other business matters. The notice · Every company's board meetings
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹88 Cr2,938th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.83
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it, the company's own balance sheet from before it began consolidating; the two agree where both are first on record.
- 6.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.27
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 88,99183.0% delivered
Vaishali Pharma share news and announcements
332 announcements, routine notices left out, newest first. Page 6 of 7.
Jul 2020
30 Jul · Results
30 Jul · Board meeting
23 Jul · Board meeting
Jun 2020
May 2020
29 May · Business
Apr 2020
13 Apr · Updates
Feb 2020
6 Feb · Updates
Jan 2020
16 Jan · Updates
Dec 2019
31 Dec · Board meeting
18 Dec · Updates
13 Dec · Legal
Exchange has sought clarification from Vaishali Pharma Limited with respect to announcement dated 11-Dec-2019 regarding Board meeting held on December 11 2019 for appointment of Company Secretary". On basis of above the Company is required to clarify following: 1. Brief profile in case of appointment of Mrs. Pooja Garg. The response of the Company is awaited.11 Dec · Board meeting
Nov 2019
14 Nov · Board meeting
14 Nov · Results
Oct 2019
15 Oct · Corporate action
Sep 2019
30 Sep · Amendment to AOA/MOA
Aug 2019
29 Aug · Meeting